Product Code: ETC4472305 | Publication Date: Jul 2023 | Updated Date: Aug 2025 | Product Type: Report | |
Publisher: 6Wresearch | No. of Pages: 85 | No. of Figures: 45 | No. of Tables: 25 | |
The India Radioimmunoassay market has evolved as a vital component of diagnostic testing, particularly for hormones, proteins, and drugs. Radioimmunoassay techniques use radioactive markers to measure specific substances in the blood, making it a highly sensitive and accurate method. The market has grown due to the demand for precise diagnostic tools in endocrinology, oncology, and drug monitoring. Technological advancements have enhanced safety and reduced radiation exposure, improving the appeal of this method. The market`s expansion is expected to continue as healthcare providers prioritize precise diagnostic tools for a range of conditions.
The India radioimmunoassay market benefits from the need for highly sensitive and specific assays in clinical research and diagnosis. This market is driven by the increasing prevalence of cancer and autoimmune diseases, which require accurate biomarker measurements. Ongoing research and developments in radioimmunoassay technologies support its growth.
The India radioimmunoassay market faces challenges related to the complexity of the technique, cost, and radioactive materials handling. Radioimmunoassay involves the use of radioactive substances, which require stringent safety protocols and trained personnel. The cost of setting up and maintaining radioimmunoassay facilities can be prohibitive, limiting accessibility. Additionally, ensuring proper disposal and handling of radioactive materials is a regulatory concern.
The radioimmunoassay market was impacted by supply chain disruptions and the diversion of resources towards COVID-19 testing. However, it remained relevant in diagnosing specific diseases and monitoring certain conditions.
Key players in the India Radioimmunoassay Market include DiaSorin S.p.A., PerkinElmer, Inc., IBL International, DRG International, and MP Biomedicals, known for their expertise in developing radioimmunoassay kits and related technologies.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Radioimmunoassay Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Radioimmunoassay Market Revenues & Volume, 2021 & 2031F |
3.3 India Radioimmunoassay Market - Industry Life Cycle |
3.4 India Radioimmunoassay Market - Porter's Five Forces |
3.5 India Radioimmunoassay Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.6 India Radioimmunoassay Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 India Radioimmunoassay Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 India Radioimmunoassay Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic diseases in India |
4.2.2 Growing demand for diagnostic tests for early disease detection |
4.2.3 Technological advancements in radioimmunoassay techniques |
4.3 Market Restraints |
4.3.1 High cost associated with radioimmunoassay tests |
4.3.2 Limited awareness about radioimmunoassay testing in certain regions of India |
4.3.3 Stringent regulatory requirements for radioimmunoassay products |
5 India Radioimmunoassay Market Trends |
6 India Radioimmunoassay Market, By Types |
6.1 India Radioimmunoassay Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 India Radioimmunoassay Market Revenues & Volume, By Product, 2021-2031F |
6.1.3 India Radioimmunoassay Market Revenues & Volume, By Analyzers, 2021-2031F |
6.1.4 India Radioimmunoassay Market Revenues & Volume, By Reagents and Kits, 2021-2031F |
6.2 India Radioimmunoassay Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 India Radioimmunoassay Market Revenues & Volume, By Research, 2021-2031F |
6.2.3 India Radioimmunoassay Market Revenues & Volume, By Clinical Diagnostics, 2021-2031F |
6.3 India Radioimmunoassay Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 India Radioimmunoassay Market Revenues & Volume, By Hospitals, 2021-2031F |
6.3.3 India Radioimmunoassay Market Revenues & Volume, By Clinical Diagnostic Laboratories, 2021-2031F |
6.3.4 India Radioimmunoassay Market Revenues & Volume, By Pharmaceutical Industries, 2021-2031F |
6.3.5 India Radioimmunoassay Market Revenues & Volume, By Other End Users, 2021-2031F |
7 India Radioimmunoassay Market Import-Export Trade Statistics |
7.1 India Radioimmunoassay Market Export to Major Countries |
7.2 India Radioimmunoassay Market Imports from Major Countries |
8 India Radioimmunoassay Market Key Performance Indicators |
8.1 Adoption rate of radioimmunoassay tests in India |
8.2 Number of research studies and publications using radioimmunoassay in India |
8.3 Investment in RD for radioimmunoassay technologies in India |
9 India Radioimmunoassay Market - Opportunity Assessment |
9.1 India Radioimmunoassay Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 India Radioimmunoassay Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 India Radioimmunoassay Market Opportunity Assessment, By End User, 2021 & 2031F |
10 India Radioimmunoassay Market - Competitive Landscape |
10.1 India Radioimmunoassay Market Revenue Share, By Companies, 2024 |
10.2 India Radioimmunoassay Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |